Rheumatoid Arthritis Increases Risk for New Heart Failure
By Lori Solomon HealthDay Reporter
FRIDAY, Dec. 20, 2024 -- Rheumatoid arthritis (RA) is associated with a higher rate of heart failure subtypes, according to a study published online Dec. 9 in Arthritis Care & Research.
Yumeko Kawano, M.D., from Brigham and Women’s Hospital in Boston, and colleagues evaluated the risk for heart failure subtypes in patients with RA compared to non-RA controls. The analysis included 1,445 patients with RA and 4,335 matched non-RA controls.
The researchers found that heart failure with preserved ejection fraction (HFpEF) was the most common heart failure subtype in both groups (65 percent in RA versus 59 percent in non-RA). Patients with RA had a higher risk for incident heart failure than those without RA (hazard ratio, 1.79) when adjusting for cardiovascular disease risk factors. Patients with RA also had a higher rate of HFpEF (hazard ratio, 1.99). However, there was no statistical difference in the heart failure with reduced ejection fraction rate.
"The elevated risk was driven by HFpEF, supporting a role for inflammation in HFpEF and highlighting potential opportunities to address this excess risk in RA," the authors write. "Since inflammation is modifiable with anti-inflammatory medications, further studies are needed to determine whether anti-inflammatory therapies have the potential to reduce risk of HFpEF in RA and other individuals with chronic inflammation."
Several authors disclosed ties to industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Exposure to Certain HIV Drugs May Significantly Lower Risk for Alzheimer Disease
TUESDAY, May 20, 2025 -- Exposure to nucleoside reverse transcriptase inhibitors (NRTIs), which treat HIV and hepatitis B and inhibit inflammasome activation, is associated with a...
AI Tools Can Predict Left Ventricular Dysfunction in Women of Reproductive Age
WEDNESDAY, May 14, 2025 -- Artificial intelligence (AI) tools are effective for detecting left ventricular systolic dysfunction (LVSD) among women of reproductive age seen in...
CVD Mortality Higher in Women Than Men With Immune-Mediated Inflammatory Diseases
TUESDAY, May 13, 2025 -- For patients with immune-mediated inflammatory diseases (IMID), cardiovascular disease (CVD) mortality decreased from 1999 to 2020, but sex disparities...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.